loadpatents
Patent applications and USPTO patent grants for KUGELMANN; Heinrich.The latest application filed is for "abuse-proofed oral dosage form".
Patent | Date |
---|---|
Abuse-proofed Oral Dosage Form App 20200397704 - BARTHOLOMAUS; Johannes ;   et al. | 2020-12-24 |
Abuse-proofed Dosage Form App 20200375905 - BARTHOLOMAEUS; JOHANNES ;   et al. | 2020-12-03 |
Abuse-proofed Dosage Form App 20200215053 - ARKENAU-MARIC; Elisabeth ;   et al. | 2020-07-09 |
Abuse-proofed Dosage Form App 20200188333 - BARTHOLOMAUS; Johannes ;   et al. | 2020-06-18 |
Crush resistant delayed-release dosage forms Grant 10,675,278 - | 2020-06-09 |
Abuse-proofed Oral Dosage Form App 20200038330 - BARTHOLOMAUS; Johannes ;   et al. | 2020-02-06 |
Abuse-proofed Oral Dosage Form App 20200009082 - BARTHOLOMAUS; Johannes ;   et al. | 2020-01-09 |
Abuse-proofed Dosage Form App 20190321358 - ARKENAU-MARIC; Elisabeth ;   et al. | 2019-10-24 |
Abuse-proofed Dosage Form App 20190282506 - BARTHOLOMAEUS; JOHANNES ;   et al. | 2019-09-19 |
Abuse-proofed dosage form Grant 10,369,109 - Bartholomaeus , et al. | 2019-08-06 |
Abuse-proofed Oral Dosage Form App 20190142767 - BARTHOLOMAUS; Johannes ;   et al. | 2019-05-16 |
Abuse-proofed Dosage Form App 20190029976 - BARTHOLOMAUS; Johannes ;   et al. | 2019-01-31 |
Abuse-proofed Dosage Form App 20190008849 - ARKENAU MARIC; Elisabeth ;   et al. | 2019-01-10 |
Crush Resistant Delayed-release Dosage Forms App 20180369235 - ASHWORTH; Judy ;   et al. | 2018-12-27 |
Pharmaceutical salts Grant 10,160,719 - Bartholomaus , et al. Dec | 2018-12-25 |
Abuse-proofed dosage form Grant 10,130,591 - Bartholomaus , et al. November 20, 2 | 2018-11-20 |
Abuse-proofed Dosage Form App 20180318223 - BARTHOLOMAEUS; JOHANNES ;   et al. | 2018-11-08 |
Abuse-proofed Dosage Form App 20180243237 - Arkenau-Maric; Elisabeth ;   et al. | 2018-08-30 |
Abuse-proofed dosage form Grant 10,058,548 - Arkenau-Maric , et al. August 28, 2 | 2018-08-28 |
Abuse-proofed Oral Dosage Form App 20180235908 - BARTHOLOMAUS; Johannes ;   et al. | 2018-08-23 |
Abuse-proofed Oral Dosage Form App 20180147149 - Bartholomaus; Johannes ;   et al. | 2018-05-31 |
Crush Resistant Delayed-release Dosage Forms App 20170312271 - ASHWORTH; Judy ;   et al. | 2017-11-02 |
Abuse-proofed Dosage Form App 20170239185 - BARTHOLOMAEUS; JOHANNES ;   et al. | 2017-08-24 |
Abuse-proofed Dosage Form App 20170209379 - ARKENAU-MARIC; Elisabeth ;   et al. | 2017-07-27 |
Abuse-proofed Oral Dosage Form App 20170209378 - BARTHOLOMAUS; JOHANNES ;   et al. | 2017-07-27 |
Abuse-proofed dosage form Grant 9,675,610 - Bartholomaeus , et al. June 13, 2 | 2017-06-13 |
Abuse-proofed dosage form Grant 9,629,807 - Arkenau-Maric , et al. April 25, 2 | 2017-04-25 |
Abuse-proofed dosage forms App 20170027886 - BARTHOLOMAUS; Johannes ;   et al. | 2017-02-02 |
Abuse-proofed Dosage Form App 20170000739 - BARTHOLOMAUS; Johannes ;   et al. | 2017-01-05 |
Abuse-proofed Dosage Form App 20160374963 - ARKENAU-MARIC; ELISABETH ;   et al. | 2016-12-29 |
Process For The Production Of An Abuse-proofed Solid Dosage Form App 20160367501 - ARKENAU-MARIC; Elisabeth ;   et al. | 2016-12-22 |
Abuse-proofed Oral Dosage Form App 20160367549 - BARTHOLOMAUS; JOHANNES ;   et al. | 2016-12-22 |
Process For The Production Of An Abuse-proofed Solid Dosage Form App 20160367484 - ARKENAU-MARIC; Elisabeth ;   et al. | 2016-12-22 |
Abuse-proofed Dosage Form App 20160361306 - BARTHOLOMAEUS; JOHANNES ;   et al. | 2016-12-15 |
Abuse-proofed Dosage Form App 20160361308 - BARTHOLOMAUS; Johannes ;   et al. | 2016-12-15 |
Abuse-proofed Dosage Form App 20160263037 - ARKENAU MARIC; Elisabeth ;   et al. | 2016-09-15 |
Abuse-proofed oral dosage form App 20160220517 - BARTHOLOMAUS; Johannes ;   et al. | 2016-08-04 |
Abuse-proofed Oral Dosage Form App 20160184295 - BARTHOLOMAUS; Johannes ;   et al. | 2016-06-30 |
Crush Resistant Delayed-release Dosage Forms App 20160184297 - ARKENAU-MARIC; Elisabeth ;   et al. | 2016-06-30 |
Abuse-proofed Oral Dosage Form App 20160175256 - BARTHOLOMAUS; JOHANNES ;   et al. | 2016-06-23 |
Abuse-proofed Dosage Form App 20160166517 - ARKENAU-MARIC; ELISABETH ;   et al. | 2016-06-16 |
Crush Resistant Delayed-release Dosage Forms App 20160120810 - Ashworth; Judy ;   et al. | 2016-05-05 |
Process For The Production Of An Abuse-proofed Solid Dosage Form App 20160101022 - ARKENAU-MARIC; Elisabeth ;   et al. | 2016-04-14 |
Abuse-proofed Dosage Form App 20160074388 - BARTHOLOMAUS; Johannes ;   et al. | 2016-03-17 |
Process For The Production Of An Abuse-proofed Solid Dosage Form App 20160058710 - ARKENAU MARIC; Elisabeth ;   et al. | 2016-03-03 |
Abuse-proofed Oral Dosage Form App 20160022588 - BARTHOLOMAUS; Johannes ;   et al. | 2016-01-28 |
Abuse-proofed Dosage Form App 20160022587 - ARKENAU MARIC; Elisabeth ;   et al. | 2016-01-28 |
Crush resistant delayed-release dosage forms App 20150374630 - ARKENAU MARIC; Elisabeth ;   et al. | 2015-12-31 |
Abuse-proofed Dosage Form App 20150359747 - ARKENAU-MARIC; ELISABETH ;   et al. | 2015-12-17 |
Abuse-proofed Oral Dosage Form App 20150313845 - BARTHOLOMAUS; Johannes ;   et al. | 2015-11-05 |
Crush resistant delayed-release dosage forms App 20150290138 - ARKENAU-MARIC; Elisabeth ;   et al. | 2015-10-15 |
Abuse-proofed Oral Dosage Form App 20150216821 - BARTHOLOMAUS; Johannes ;   et al. | 2015-08-06 |
Process For The Production Of An Abuse-proofed Solid Dosage Form App 20150182464 - ARKENAU MARIC; Elisabeth ;   et al. | 2015-07-02 |
Process For The Production Of An Abuse-proofed Solid Dosage Form App 20150182465 - Arkenau Maric; Elisabeth ;   et al. | 2015-07-02 |
Plaster causing reduced skin irritation Grant 9,066,888 - Kugelmann , et al. June 30, 2 | 2015-06-30 |
Dosage That Is Safeguarded From Abuse App 20150150978 - Arkenau-Maric; Elisabeth ;   et al. | 2015-06-04 |
Abuse-proofed Dosage Form App 20150056147 - BARTHOLOMAEUS; JOHANNES ;   et al. | 2015-02-26 |
Abuse-proofed Oral Dosage Form App 20150024046 - BARTHOLOMAUS; Johannes ;   et al. | 2015-01-22 |
Dosage That Is Safeguarded From Abuse App 20140356294 - ARKENAU-MARIC; Elisabeth ;   et al. | 2014-12-04 |
Crush Resistan Delayed-release Dosage Form App 20140322311 - Ashworth; Judy ;   et al. | 2014-10-30 |
Abuse-proofed Dosage Form App 20140170079 - ARKENAU MARIC; Elisabeth ;   et al. | 2014-06-19 |
Process For The Production Of An Abuse-proofed Solid Dosage Form App 20140155489 - ARKENAU-MARIC; Elisabeth ;   et al. | 2014-06-05 |
Abuse-proofed Oral Dosage Form App 20140147499 - BARTHOLOMAUS; Johannes ;   et al. | 2014-05-29 |
Crush resistant delayed-release dosage forms App 20140112984 - ARKENAU-MARIC; Elisabeth ;   et al. | 2014-04-24 |
Abuse-proofed Oral Dosage Form App 20140112989 - Bartholomaus; Johannes ;   et al. | 2014-04-24 |
Abuse-proofed Dosage Form App 20140105830 - BARTHOLOMAUS; Johannes ;   et al. | 2014-04-17 |
Abuse-proofed Dosage Form App 20140093559 - BARTHOLOMAEUS; JOHANNES ;   et al. | 2014-04-03 |
Dosage Form That Is Safeguarded From Abuse App 20140086847 - ARKENAU MARIC; Elisabeth ;   et al. | 2014-03-27 |
Crush resistant delayed-release dosage forms App 20140079780 - ARKENAU MARIC; Elisabeth ;   et al. | 2014-03-20 |
Abuse-proofed dosage forms App 20140080915 - Bartholomaus; Johannes ;   et al. | 2014-03-20 |
Abuse-proofed dosage forms App 20140080858 - BARTHOLOMAUS; Johannes ;   et al. | 2014-03-20 |
Abuse-proofed Oral Dosage Form App 20130287846 - BARTHOLOMAUS; Johannes ;   et al. | 2013-10-31 |
Abuse-proofed Oral Dosage Form App 20130251643 - BARTHOLOMAUS; Johannes ;   et al. | 2013-09-26 |
Pharmaceutical patch for transdermal administration of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexa- ne-1,1'-pyrano[3,4-b]indol]-4-amine App 20130211351 - FUHRHERR; Richard ;   et al. | 2013-08-15 |
Abuse-proofed Dosage Form App 20130195935 - BARTHOLOMAUS; JOHANNES ;   et al. | 2013-08-01 |
Abuse-proofed Dosage Form App 20130171075 - ARKENAU-MARIC; Elisabeth ;   et al. | 2013-07-04 |
Abuse-proofed dosage form Grant 8,420,056 - Arkenau-Maric , et al. April 16, 2 | 2013-04-16 |
Abuse-proofed Dosage Form App 20120308654 - BARTHOLOMAUS; JOHANNES ;   et al. | 2012-12-06 |
Process for the production of an abuse-proofed solid dosage form Grant 8,323,889 - Arkenau-Maric , et al. December 4, 2 | 2012-12-04 |
Abuse-proofed dosage form Grant 8,309,060 - Bartholomaus , et al. November 13, 2 | 2012-11-13 |
Abuse-proofed dosage form App 20120251637 - BARTHOLOMAUS; Johannes ;   et al. | 2012-10-04 |
Abuse-proof dosage form Grant 8,192,722 - Arkenau-Maric , et al. June 5, 2 | 2012-06-05 |
Abuse-proofed dosage form App 20120135071 - Bartholomaus; Johannes ;   et al. | 2012-05-31 |
Abuse-proofed Dosage Form App 20120107250 - Bartholomaus; Johannes ;   et al. | 2012-05-03 |
Pharmaceutical Salts App 20120059066 - BARTHOLOMAUS; JOHANNES ;   et al. | 2012-03-08 |
Abuse-proofed dosage form Grant 8,114,383 - Bartholomaus , et al. February 14, 2 | 2012-02-14 |
Abuse-proofed Dosage Form App 20120034171 - ARKENAU-MARIC; Elisabeth ;   et al. | 2012-02-09 |
Oral Contraception With Trimegestone App 20120028936 - GLOGER; OLIVER ;   et al. | 2012-02-02 |
Abuse-proofed dosage form Grant 8,075,872 - Arkenau-Maric , et al. December 13, 2 | 2011-12-13 |
Application system for a plaster containing an active ingredient and a controlled-release agent for said active ingredient Grant 7,994,382 - Bartholomaeus , et al. August 9, 2 | 2011-08-09 |
Intravenous pharmaceutical form of administration Grant 7,838,034 - Kugelmann , et al. November 23, 2 | 2010-11-23 |
Oral Contraception With Trimegestone App 20100279989 - GLOGER; OLIVER ;   et al. | 2010-11-04 |
Abuse-proofed Dosage Form App 20100260833 - BARTHOLOMAUS; Johannes ;   et al. | 2010-10-14 |
Abuse-proofed dosage system Grant 7,776,314 - Bartholomaus , et al. August 17, 2 | 2010-08-17 |
Crush Resistant Delayed-release Dosage Forms App 20100151028 - Ashworth; Judy ;   et al. | 2010-06-17 |
Pharmaceutical Salts App 20090258948 - BARTHOLOMAUS; Johannes ;   et al. | 2009-10-15 |
Abuse-proof Dosage Form App 20080311049 - Arkenau-Maric; Elisabeth ;   et al. | 2008-12-18 |
System for the Oral Administration of Solids to Persons Suffering from Dementia App 20080312587 - Kugelmann; Heinrich ;   et al. | 2008-12-18 |
Application System for a Plaster Containing an Active Ingredient and a Controlled-Release Agent for Said Active Ingredient App 20080274146 - Bartholomaus; Johannes ;   et al. | 2008-11-06 |
Form Of Administration Secured Against Misuse App 20080247959 - Bartholomaus; Johannes ;   et al. | 2008-10-09 |
Abuse-proofed Oral Dosage Form App 20080248113 - Bartholomaus; Johannes ;   et al. | 2008-10-09 |
Transdermal Therapeutic System For Administering Analgesics App 20070298091 - KUGELMANN; Heinrich ;   et al. | 2007-12-27 |
Abuse-proofed dosage form App 20070183979 - Arkenau-Maric; Elisabeth ;   et al. | 2007-08-09 |
Dosage Form That Is Safeguarded From Abuse App 20070183980 - Arkenau-Maric; Elisabeth ;   et al. | 2007-08-09 |
Abuse-resistant transdermal system App 20070065365 - Kugelmann; Heinrich ;   et al. | 2007-03-22 |
Kit comprising a plaster, optionally containing an active substance, and an agent that at least partially reduces skin irritation App 20070053965 - Kugelmann; Heinrich ;   et al. | 2007-03-08 |
Abuse-proofed Dosage Form App 20070048228 - ARKENAU-MARIC; Elisabeth ;   et al. | 2007-03-01 |
Plaster causing reduced skin irritation App 20070042028 - Kugelmann; Heinrich ;   et al. | 2007-02-22 |
Oral contraception with trimegestone App 20070021396 - Gloger; Oliver ;   et al. | 2007-01-25 |
Abuse-proofed dosage form App 20060193782 - Bartholomaus; Johannes ;   et al. | 2006-08-31 |
Abuse-proofed oral dosage form App 20060039864 - Bartholomaus; Johannes ;   et al. | 2006-02-23 |
Abuse-proofed oral dosage form App 20060002860 - Bartholomaus; Johannes ;   et al. | 2006-01-05 |
Active ingredient release system comprising a plaster containing an active ingredient and at least one active ingredient release regulator App 20050249792 - Kugelmann, Heinrich | 2005-11-10 |
Abuse-safeguarded dosage form App 20050214223 - Bartholomaeus, Johannes ;   et al. | 2005-09-29 |
Opioid-receptor antagonists in transdermal systems having buprenorphine App 20050191340 - Bartholomaeus, Johannes ;   et al. | 2005-09-01 |
Pharmaceutical salts App 20050176790 - Bartholomaus, Johannes ;   et al. | 2005-08-11 |
Abuse-proofed dosage form App 20050152843 - Bartholomaus, Johannes ;   et al. | 2005-07-14 |
Intravenous pharmaceutical form of administration App 20050136120 - Kugelmann, Heinrich ;   et al. | 2005-06-23 |
Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt Grant 6,875,447 - Bartholomaus , et al. April 5, 2 | 2005-04-05 |
Abuse-proffed dosage form App 20050031546 - Bartholomaus, Johannes ;   et al. | 2005-02-10 |
Pharmaceutical tramadol salts Grant 6,723,343 - Kugelmann April 20, 2 | 2004-04-20 |
Dosage forms which can be administered parenterally and comprise a suspension of the salt of tramadol and diclofenac App 20030203037 - Bartholomaus, Johannes ;   et al. | 2003-10-30 |
Pharmaceutical tramadol salts App 20030158242 - Kugelmann, Heinrich | 2003-08-21 |
Sustained-release form of administration containing tramadol saccharinate Grant 6,576,260 - Bartholomaeus , et al. June 10, 2 | 2003-06-10 |
Sustained-release form of administration containing tramadol saccharinate App 20030035835 - Bartholomaeus, Johannes ;   et al. | 2003-02-20 |
Stable aqueous solution of 3-(1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2-6-dione Grant 6,306,879 - Germann , et al. October 23, 2 | 2001-10-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.